Application of SARS2 autoantibody detection reagent in preparation of lung cancer screening kit

An autoantibody and kit technology, applied in biological tests, measuring devices, material inspection products, etc., can solve the problems of no lung cancer existing technology, no SARS2 protein, etc., and achieve low patient harm, good application prospects, and effective The effect of screening
CN110456064AActive Publication Date: 2019-11-15WEST CHINA HOSPITAL SICHUAN UNIV +1
2 Cites 4 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
WEST CHINA HOSPITAL SICHUAN UNIV
Publication Date
2019-11-15

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of the in-vitro diagnosis reagent, and specifically relates to an application of SARS2 autoantibody detection reagent in preparation of a lung cancer screening kit.The condition that the autoantibody level of the SARS2 protein in the lung cancer patient serum is remarkably higher than that of the health patient is firstly discovered in the invention, the reagentfor detecting the autoantibody of the SARS2 protein is used for preparing the lung cancer screening kit, thereby realizing effective screening of the lung cancer.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of in vitro diagnostic reagents, in particular to the use of a SARS2 autoantibody detection reagent in the preparation of a lung cancer screening kit. Background technique

[0002] Lung cancer is one of the most common malignant tumors in the world. Its morbidity and mortality are increasing year by year. Currently, the incidence rate ranks first in the world, which seriously threatens human health and life.

[0003] Lung cancer is a disease that is good at concealment. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they are diagnosed with lung cancer symptoms. The best cure time, five-year survival rate is low. For patients with early lung cancer, timely treatment can greatly improve the 5-year survival rate and quality of life of the patients. Therefore, early diagnosis and effective screening of lung canc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More